This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
BCAN TT 2024
ASCO 2024
AUA 2024
ESMO 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Clinical evaluation of lower urinary tract symptoms following seed implant for prostate cancer - Abstract
August 1, 2012
Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome - Abstract
August 1, 2012
Salvage radiotherapy after high intensity focused ultrasound for prostate cancer - Abstract
August 1, 2012
Prostate cancer mortality risk in relation to working underground in the Wismut cohort study of German uranium miners, 1970-2003 - Abstract
August 1, 2012
A randomised controlled trial of a cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN): Trial protocol - Abstract
August 1, 2012
PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience - Abstract
August 1, 2012
Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: Practice patterns of uro-oncologists in North America - Abstract
August 1, 2012
Robustness of ProsVueâ„¢ linear slope for prognostic identification of patients at reduced risk for prostate cancer recurrence: Simulation studies on effects of analytical imprecision and sampling time variation - Abstract
August 1, 2012
Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer - Abstract
August 1, 2012
Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer - Abstract
August 1, 2012
A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer - Abstract
August 1, 2012
Priapism as the initial manifestation of a penile and lower limb cutaneous metastasis of prostate adenocarcinoma with low serum PSA level: A case report - Abstract
August 1, 2012
Factors influencing the degree of enhancement of prostate cancer on contrast-enhanced transrectal ultrasonography: Correlation with biopsy and radical prostatectomy specimens - Abstract
August 1, 2012
Therapies used in prostate cancer patients by European urologists: Data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates - Abstract
August 1, 2012
National comprehensive cancer network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer - Abstract
August 1, 2012
Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy - Abstract
August 1, 2012
The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: Results from a population-based cohort - Abstract
July 31, 2012
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro) - Abstract
July 31, 2012
Robustness Against Interfraction Prostate Movement in Scanned Ion Beam Radiation Therapy - Abstract
July 31, 2012
A Dosimetric Comparison of Tomotherapy and Volumetric Modulated Arc Therapy in the Treatment of High-Risk Prostate Cancer With Pelvic Nodal Radiation Therapy - Abstract
July 31, 2012
Page 1250 of 1421
Start
Prev
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free